HCW Biologics Inc (NASDAQ: HCWB) kicked off on Monday, up 128.58% from the previous trading day, before settling in for the closing price of $0.28. Over the past 52 weeks, HCWB has traded in a range of $0.21-$2.52.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -39.43%. While this was happening, its average annual earnings per share was recorded 18.57%. With a float of $19.75 million, this company’s outstanding shares have now reached $37.82 million.
Let’s determine the extent of company efficiency that accounts for 45 employees. In terms of profitability, gross margin is 17.59%, operating margin of -1060.88%, and the pretax margin is -1067.83%.
HCW Biologics Inc (HCWB) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of HCW Biologics Inc is 47.77%, while institutional ownership is 8.10%.
HCW Biologics Inc (HCWB) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 18.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.29% during the next five years compared to -34.57% drop over the previous five years of trading.
HCW Biologics Inc (NASDAQ: HCWB) Trading Performance Indicators
Take a look at HCW Biologics Inc’s (HCWB) current performance indicators. Last quarter, stock had a quick ratio of 0.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.00, a number that is poised to hit 0.09 in the next quarter and is forecasted to reach -0.50 in one year’s time.
Technical Analysis of HCW Biologics Inc (HCWB)
Looking closely at HCW Biologics Inc (NASDAQ: HCWB), its last 5-days average volume was 69.45 million, which is a jump from its year-to-date volume of 16.65 million. As of the previous 9 days, the stock’s Stochastic %D was 42.17%. Additionally, its Average True Range was 0.10.
During the past 100 days, HCW Biologics Inc’s (HCWB) raw stochastic average was set at 18.43%, which indicates a significant decrease from 51.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 361.17% in the past 14 days, which was higher than the 292.65% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4410, while its 200-day Moving Average is $0.6706. However, in the short run, HCW Biologics Inc’s stock first resistance to watch stands at $0.9295. Second resistance stands at $1.2230. The third major resistance level sits at $1.4161. If the price goes on to break the first support level at $0.4429, it is likely to go to the next support level at $0.2498.
HCW Biologics Inc (NASDAQ: HCWB) Key Stats
The company with the Market Capitalisation of 24.05 million has total of 37,823K Shares Outstanding. Its annual sales at the moment are 2,840 K in contrast with the sum of -24,990 K annual income. Company’s last quarter sales were recorded 430 K and last quarter income was -3,900 K.
